SCHEMBL6784824

SCHEMBL6784824

COC(=O)c1ccc(NCCN(C)C)cc1NC(=O)/C=C(/C)c1ccc2ccccc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 5/20 0.52
TNIK Q9UKE5 1/20 0.43
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 5/20 0.41
ALOX12 P18054 1/20 0.41
SYK P43405 1/20 0.39
HTT P42858 2/20 0.39
MAPT P10636 1/20 0.39
ATM Q13315 2/20 0.39
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX5 P09917 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
THRB P10828 1/20 0.38
NPC1 O15118 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6786450 0.91 TERT (0.64) TERTTNIKALDH1A1KDM4ESYK
SCHEMBL6782347 0.90 TERT (0.55) TERTALDH1A1KDM4EALOX12HTT
SCHEMBL6784666 0.87 TERT (0.52) TERTALDH1A1KDM4EALOX12ATM
SCHEMBL6785041 0.85 TERT (0.56) TERTALDH1A1KDM4EALOX12HTT
SCHEMBL6787758 0.84 TERT (0.51) TERTALDH1A1KDM4EALOX12ALOX5
SCHEMBL7527436 0.83 TERT (0.56) TERTALDH1A1KDM4EALOX12HTT
SCHEMBL6784205 0.83 TERT (0.60) TERTALDH1A1KDM4EALOX12HTT
SCHEMBL6782397 0.82 TERT (0.64) TERTALDH1A1KDM4EALOX12HTT
SCHEMBL6786375 0.82 TERT (0.57) TERTALDH1A1KDM4EALOX12HTT
SCHEMBL6787598 0.82 TERT (0.59) TERTALDH1A1KDM4EALOX12HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6727250-B2 ADMINISTERING COMPOUNDS SUCH AS TRANS-3-(NAPHTH-2-YL)-BUT-2-ENOIC ACID-N-(2-CARBOXY-PHENYL)-AMIDE OR LIKE FOR THERAPY OF CONDITIONS ASSOCIATED WITH INCREASED TELOMERASE ACTIVITY, E.G. TUMOUR DISEASES BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-04-27 US disclosed
US-20020099089-A1 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and preparation BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-07-25 US disclosed
US-6362210-B1 ANTITUMOR, ANTICANCER AGENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099089-A1 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and preparation TERT, NAT1, POT1 TERT 1/4885TNIK 2085/4885ALDH1A1 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.